WuXi AppTec (OTCMKTS:WUXAY) Shares Gap Up – Here’s Why

WuXi AppTec Co., Ltd. (OTCMKTS:WUXAY) shares gapped up prior to trading on Monday . The stock had previously closed at $15.60, but opened at $16.66. WuXi AppTec shares last traded at $16.66, with a volume of 200 shares traded.

Analysts Set New Price Targets

Separately, Zacks Research raised shares of WuXi AppTec to a “hold” rating in a report on Monday, April 13th. One equities research analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, WuXi AppTec has a consensus rating of “Moderate Buy”.

WuXi AppTec Stock Performance

The business has a 50 day moving average of $16.37 and a 200-day moving average of $14.98.

WuXi AppTec (OTCMKTS:WUXAY) last issued its earnings results on Monday, April 27th. The company reported $0.23 EPS for the quarter, topping the consensus estimate of $0.18 by $0.05. The company had revenue of $1.82 billion during the quarter, compared to the consensus estimate of $1.59 billion.

WuXi AppTec Company Profile

WuXi AppTec is a global contract research, development and manufacturing organization serving the pharmaceutical, biotechnology and medical device industries. Headquartered in Shanghai and founded in 2000, the company provides end-to-end solutions that span drug discovery, development and manufacturing. Its offerings enable customers to accelerate the research and development process for small molecules, biologics, cell and gene therapies, as well as medical devices.

Key services include chemistry and biology discovery support, preclinical safety assessment, analytical and formulation development, clinical manufacturing, large-scale biomanufacturing, and quality testing.